HOTAIR and breast cancer: Additionally, serum HOTAIR levels effectively distinguished patients with stage III/IV breast cancer from those with earlier stages, exhibiting 75% sensitivity and 64% specificity (AUC = 0.698 at the cutoff point of 13.69-fold) (Fig. 4).